1 Department of Biochemistry, University of Nebraska , Lincoln, Nebraska.
2 Ionis Pharmaceuticals , Carlsbad, California.
Nucleic Acid Ther. 2018 Apr;28(2):86-96. doi: 10.1089/nat.2017.0694. Epub 2018 Feb 13.
Second-generation (Gen 2) Antisense oligonucleotides (ASOs) show increased nuclease stability and affinity for their RNA targets, which has translated to improved potency and therapeutic index in the clinic. Gen 2 ASOs are typically modified using the phosphorothioate (PS) backbone modification, which enhances ASO interactions with plasma, cell surface, and intracellular proteins. This facilitates ASO distribution to peripheral tissues and also promotes cellular uptake after injection into animals. Previous work identified that Stabilin receptors specifically internalize PS-ASOs in the sinusoidal endothelial cells of the liver and the spleen. By modulating expression of specific proteins involved in the trafficking and maturation of the endolysosomal compartments, we show that Rab5C and EEA1 in the early endosomal pathway, and Rab7A and lysobisphosphatidic acid in the late endosomal pathway, are important for trafficking of PS-ASOs and facilitate their escape from endolysosomal compartments after Stabilin-mediated internalization. In conclusion, this work identifies key rate-limiting proteins in the pathway for PS-ASO translocation and escape from the endosome.
第二代(Gen 2)反义寡核苷酸(ASO)具有更高的核酸酶稳定性和与 RNA 靶标结合的亲和力,这在临床上转化为提高了的效力和治疗指数。Gen 2 ASO 通常使用硫代磷酸酯(PS)骨架修饰进行修饰,这增强了 ASO 与血浆、细胞表面和细胞内蛋白的相互作用。这有助于 ASO 分布到外周组织,并在注射到动物体内后促进细胞摄取。以前的工作表明,稳定素受体特异性地将 PS-ASO 内化到肝脏和脾脏的窦状内皮细胞中。通过调节参与内体运输和成熟的特定蛋白质的表达,我们表明早期内体途径中的 Rab5C 和 EEA1,以及晚期内体途径中的 Rab7A 和溶血磷脂酸,对于 PS-ASO 的运输很重要,并促进它们在稳定素介导的内化后从内体中逃逸。总之,这项工作确定了 PS-ASO 易位和从内体逃逸途径中的关键限速蛋白。